Ceftriaxon Labatec 250 mg i.m.
Ceftriaxon Labatec 250 mg i.m. is a medicine authorised by Swissmedic under authorisation number 59876. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 February 2010 and the authorisation is valid without a time limit. ATC code J01DD04 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 59876 |
|---|---|
| Name | Ceftriaxon Labatec 250 mg i.m. |
| Full name | Ceftriaxon Labatec 250 mg i.m., poudre pour solution injectable |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01DD04 |
| First authorisation | 25 February 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ceftriaxon Labatec 250 mg i.m., poudre pour solution injectable | A | 25 February 2010 |
| 2 | Ceftriaxon Labatec 500 mg i.v., poudre pour solution injectable | A | 25 February 2010 |
| 3 | Ceftriaxon Labatec 1 g i.v./i.m., poudre pour solution injectable | A | 25 February 2010 |
| 4 | Ceftriaxon Labatec 2 g i.v., poudre pour solution pour perfusion | A | 25 February 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 x 250 | mg | J01DD04 | 08.01.3. | A |
| 2 | 10 x 500 | mg | J01DD04 | 08.01.3. | A |
| 3 | 10 x 1 | g | J01DD04 | 08.01.3. | A |
| 6 | 1 x 1 | g | J01DD04 | 08.01.3. | A |
| 5 | 10 x 2 | g | J01DD04 | 08.01.3. | A |
| 7 | 1 x 2 | g | J01DD04 | 08.01.3. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ceftriaxon Labatec 250 mg i.m. authorised in Switzerland?
Yes. Ceftriaxon Labatec 250 mg i.m. is authorised by Swissmedic under authorisation number 59876, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ceftriaxon Labatec 250 mg i.m. have?
Ceftriaxon Labatec 250 mg i.m. is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ceftriaxon Labatec 250 mg i.m.?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.